13F HOLDINGS REPORT
Logos Global Management LP
Quarter ended Q3 2023 · Filed August 14, 2023 · Accession 0001172661-23-003013
Total Value
$735.2M
Positions
51
Other Managers
0
Confidential Omitted
No
Holdings (51)
| # | Issuer | Ticker / CUSIP | Shares | Value | % of Filing |
|---|---|---|---|---|---|
| 1 | APELLIS PHARMACEUTICALS INC | APLS | 625,000 | $56.9M | 7.74% |
| 2 | CYTOKINETICS INC | CYTK | 1,650,000 | $53.8M | 7.32% |
| 3 | IMMUNOVANT INC | IMVT | 2,250,000 | $42.7M | 5.81% |
| 4 | IDEAYA BIOSCIENCES INC | IDYA | 1,750,000 | $41.1M | 5.59% |
| 5 | SAREPTA THERAPEUTICS INC | SRPT | 300,000 | $34.4M | 4.67% |
| 6 | OLEMA PHARMACEUTICALS INC | OLMA | 3,743,875 | $33.8M | 4.60% |
| 7 | IMMUNOCORE HLDGS PLC | IMCR | 500,000 | $30.0M | 4.08% |
| 8 | BIOGEN INC | BIIB | 100,000 | $28.5M | 3.87% |
| 9 | NEUROCRINE BIOSCIENCES INC | NBIX | 300,000 | $28.3M | 3.85% |
| 10 | VIRIDIAN THERAPEUTICS INC | VRDN | 1,125,000 | $26.8M | 3.64% |
| 11 | AKERO THERAPEUTICS INC | 00973Y108 | 520,000 | $24.3M | 3.30% |
| 12 | ALLAKOS INC | 01671P100 | 5,250,000 | $22.9M | 3.11% |
| 13 | ICOSAVAX INC | 45114M109 | 2,165,741 | $21.5M | 2.93% |
| 14 | DYNE THERAPEUTICS INC | DYN | 1,780,000 | $20.0M | 2.72% |
| 15 | DESIGN THERAPEUTICS INC | DSGN | 2,797,501 | $17.6M | 2.40% |
| 16 | STRUCTURE THERAPEUTICS INC | GPCR | 400,000 | $16.6M | 2.26% |
| 17 | ARCELLX INC | ACLX | 500,000 | $15.8M | 2.15% |
| 18 | ARCUS BIOSCIENCES INC | RCUS | 750,000 | $15.2M | 2.07% |
| 19 | BICYCLE THERAPEUTICS PLC | BCYC | 520,000 | $13.3M | 1.80% |
| 20 | ANNEXON INC | ANNX | 3,500,000 | $12.3M | 1.68% |
| 21 | BRIDGEBIO PHARMA INC | BBIO | 650,000 | $11.2M | 1.52% |
| 22 | XENON PHARMACEUTICALS INC | XENE | 275,000 | $10.6M | 1.44% |
| 23 | GALAPAGOS NV | GLPGF | 250,000 | $10.2M | 1.38% |
| 24 | COGENT BIOSCIENCES INC | COGT | 800,000 | $9.5M | 1.29% |
| 25 | MERSANA THERAPEUTICS INC | 59045L106 | 2,800,000 | $9.2M | 1.25% |
| 26 | MORPHOSYS AG | 617760202 | 1,200,000 | $9.0M | 1.22% |
| 27 | BIOMARIN PHARMACEUTICAL INC | BMRN | 100,000 | $8.7M | 1.18% |
| 28 | VENTYX BIOSCIENCES INC | 92332V107 | 250,000 | $8.2M | 1.12% |
| 29 | DAY ONE BIOPHARMACEUTICALS I | DAWN | 650,000 | $7.8M | 1.06% |
| 30 | KARUNA THERAPEUTICS INC | 48576A100 | 35,000 | $7.6M | 1.03% |
| 31 | ALX ONCOLOGY HLDGS INC | ALXO | 1,000,000 | $7.5M | 1.02% |
| 32 | GERON CORP | GERN | 2,200,000 | $7.1M | 0.96% |
| 33 | DELCATH SYS INC | DCTH | 1,178,787 | $6.9M | 0.93% |
| 34 | GRACELL BIOTECHNOLOGIES INC | 38406L103 | 1,800,000 | $6.9M | 0.93% |
| 35 | ENLIVEN THERAPEUTICS INC | ELVN | 307,076 | $6.3M | 0.85% |
| 36 | IMMATICS N.V | IMTX | 500,000 | $5.8M | 0.78% |
| 37 | MARINUS PHARMACEUTICALS INC | 56854Q200 | 525,000 | $5.7M | 0.78% |
| 38 | ACLARIS THERAPEUTICS INC | ACRS | 525,000 | $5.4M | 0.74% |
| 39 | KURA ONCOLOGY INC | KURA | 500,000 | $5.3M | 0.72% |
| 40 | BRIDGEBIO PHARMA INC | BBIO | 300,000 | $5.2M | 0.70% |
| 41 | ROCKET PHARMACEUTICALS INC | RCKTW | 250,000 | $5.0M | 0.68% |
| 42 | VIR BIOTECHNOLOGY INC | VIR | 200,000 | $4.9M | 0.67% |
| 43 | ASTRIA THERAPEUTICS INC | 04635X102 | 544,960 | $4.5M | 0.62% |
| 44 | TENAYA THERAPEUTICS INC | TNYA | 600,000 | $3.5M | 0.48% |
| 45 | DBV TECHNOLOGIES S A | DBVTF | 1,200,000 | $2.3M | 0.31% |
| 46 | VIGIL NEUROSCIENCE INC | 92673K108 | 188,390 | $1.8M | 0.24% |
| 47 | AEGLEA BIOTHERAPEUTICS INC | 00773J103 | 3,142,880 | $1.4M | 0.19% |
| 48 | IMMUNIC INC | IMUX | 421,184 | $1.1M | 0.14% |
| 49 | LIANBIO | LIANY | 280,000 | $638,400 | 0.09% |
| 50 | TYRA BIOSCIENCES INC | TYRA | 31,872 | $542,780 | 0.07% |
| 51 | NUVATION BIO INC | NUVB | 66,666 | $11,027 | 0.00% |